Stereotaxis (STXS) reiterates its expectation of double-digit revenue growth for the full year 2025, with system revenue of $2M-$3M per quarter and recurring revenue scaling throughout the year to $7M in the fourth quarter. These revenue expectations assume only modest contributions from GenesisX in Europe and no system revenue from China. Anticipated regulatory milestones and initial commercial launches in 2025 support substantial growth in 2026. Growing recurring revenue and stable operating expenses support Stereotaxis’ expectation for reduced cash use in 2025 compared to 2024. Stereotaxis expects its balance sheet to allow it to advance its transformative product ecosystem to market, fund its commercialization, and profitably grow.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STXS:
- Stereotaxis reports Q1 EPS (7c), consensus (7c)
- Stereotaxis (STXS) Q1 Earnings Cheat Sheet
- Stereotaxis to feature first-ever live demo of GenesisX Robotic System
- Stereotaxis management to meet virtually with Lake Street
- Strategic Advancements Propel Stereotaxis: Buy Rating Affirmed Following NVIDIA Partnership
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue